Mersana Therapeutics Inc (MRSN)
2.94
+0.09
(+3.16%)
USD |
NASDAQ |
Apr 26, 16:00
2.925
-0.02
(-0.51%)
After-Hours: 20:00
Mersana Therapeutics Price to Book Value: 9.664 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 9.664 |
April 25, 2024 | 9.368 |
April 24, 2024 | 9.466 |
April 23, 2024 | 10.55 |
April 22, 2024 | 10.35 |
April 19, 2024 | 10.68 |
April 18, 2024 | 10.98 |
April 17, 2024 | 11.57 |
April 16, 2024 | 12.36 |
April 15, 2024 | 12.46 |
April 12, 2024 | 12.52 |
April 11, 2024 | 12.23 |
April 10, 2024 | 12.18 |
April 09, 2024 | 13.48 |
April 08, 2024 | 13.67 |
April 05, 2024 | 14.07 |
April 04, 2024 | 13.97 |
April 03, 2024 | 14.63 |
April 02, 2024 | 13.87 |
April 01, 2024 | 14.53 |
March 28, 2024 | 14.73 |
March 27, 2024 | 14.76 |
March 26, 2024 | 14.13 |
March 25, 2024 | 14.04 |
March 22, 2024 | 15.45 |
Date | Value |
---|---|
March 21, 2024 | 15.81 |
March 20, 2024 | 15.91 |
March 19, 2024 | 16.30 |
March 18, 2024 | 15.97 |
March 15, 2024 | 16.57 |
March 14, 2024 | 16.45 |
March 13, 2024 | 18.87 |
March 12, 2024 | 18.54 |
March 11, 2024 | 18.70 |
March 08, 2024 | 19.00 |
March 07, 2024 | 19.23 |
March 06, 2024 | 18.87 |
March 05, 2024 | 18.97 |
March 04, 2024 | 18.90 |
March 01, 2024 | 19.52 |
February 29, 2024 | 17.88 |
February 28, 2024 | 15.94 |
February 27, 2024 | 14.04 |
February 26, 2024 | 13.35 |
February 23, 2024 | 12.46 |
February 22, 2024 | 12.36 |
February 21, 2024 | 12.07 |
February 20, 2024 | 11.87 |
February 16, 2024 | 12.43 |
February 15, 2024 | 12.56 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6785
Minimum
Sep 26 2019
24.74
Maximum
Jun 25 2020
5.438
Average
4.736
Median
Dec 08 2023
Price to Book Value Benchmarks
Amicus Therapeutics Inc | 18.96 |
Geron Corp | 8.347 |
TG Therapeutics Inc | 12.96 |
Editas Medicine Inc | 1.247 |
G1 Therapeutics Inc | 5.886 |
Price to Book Value Related Metrics
PS Ratio | 9.260 |
Price | 2.94 |
Earnings Yield | -51.02% |
Market Cap | 356.63M |